COLLEYVILLE, TX--(Marketwire - October 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced that the Company has signed a contract with Dr. Matthew Teltser of the University Heart Institute in Pembroke Pines, Florida to implement the Company's proprietary Microsoft .Net-based digital prescription handling software, digiRX, and digiReauth, the Company's call center services, to support the reauthorization of prescriptions. Dr. Teltser, board certified with the American College of Cardiology and the American Board of Internal Medicine, received his medical degree from New Jersey Medical School in Newark, New Jersey.

digiMedical has operations in both Texas and Florida and, this year, has been actively expanding in Florida by signing a multitude of contracts with doctors and clinics to implement the Company's proprietary digital prescription software and reauthorization call center services. Since launching those efforts, they have signed contracts with doctors in Florida to include: Drs. Griffin, Parker, Heitmann and Floreani of A Woman's Place, Dr. Steven Bello and Dr. Thomas Magardino of Collier Otolaryngology, Dr. Richard Wilson, Drs. Angela Marshall, Wendy Humphrey and Betsy Brothers of Southwest Florida Women's Group, P.A., Dr. Daniel Kaplan, Dr. Moorthy of Pain Management Center of Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology, Drs. Romero, Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, Dr. John Landi, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of the Neuroscience and Spine Associates in Naples, Florida, among others.

digiMedical's Prescription Handling Software

digiMedical has built a suite of proprietary Microsoft .Net-based software to digitally and securely manage prescriptions in both doctor and clinic offices and in pharmacies. The software is compatible with most medical office software and is easy to install. With the software, the digital prescriptions are routed directly and securely from the physician's office or clinic to the pharmacy. The digital pack of information also already contains pertinent patient information, allowing the pharmacy to pre-fill the prescription prior to the patient's arrival at the pharmacy.

The Company's digital prescription software suite meets HIPAA and DEA requirements and helps protect the pharmacist from errors caused by difficult-to-read handwritten prescriptions and the risk to the pharmacist of illegally duplicated prescriptions and fraudulent prescriptions. Additionally, digiMedical manages prescription refills for physicians' offices and clinics through the Company's digiReauth software and call center services. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.

Company Updates and Information

digiMedical's software, which is currently in use in pharmacies in Naples and Ft. Meyers, Florida, and in Dallas, Texas, is now available for implementation nationwide in independent and chain pharmacies. If you are interested in learning more about digiMedical's software, or implementing the Company's proprietary technology in your pharmacy, please contact the Company at or 1-877-450-8181.

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to request additional information about the Company, please send an e-mail to

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ ( is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The Company's digital prescription handling software captures and transmits prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 Sales: 1-877-450-8181